Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.6K
Overview
44.6K
Cancer Vaccines01:30

Cancer Vaccines

383
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
383
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

486
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
486
Active versus Passive Immunity01:31

Active versus Passive Immunity

663
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
663
Development of Immunocompetence01:22

Development of Immunocompetence

320
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
320
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

742
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
742

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When Reassurance Falls Short: Rethinking Vaccine Risk Communication.

Monoclonal antibodies in immunodiagnosis and immunotherapy·2025
Same author

The Gift That Keeps on Giving.

Monoclonal antibodies in immunodiagnosis and immunotherapy·2024
Same author

Should We Be Worried.

Monoclonal antibodies in immunodiagnosis and immunotherapy·2024
Same author

Is It Time to Re-Evaluate?

Monoclonal antibodies in immunodiagnosis and immunotherapy·2023
Same author

Thoughts on mRNA Vaccine Response.

Monoclonal antibodies in immunodiagnosis and immunotherapy·2023
Same author

VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen.

International journal of molecular sciences·2023

Related Experiment Video

Updated: Jul 12, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.3K

Where Are We with COVID Boosters?

Thomas Kieber-Emmons

    Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
    |October 20, 2023
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
    08:48

    Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

    Published on: February 16, 2022

    2.9K
    A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
    11:17

    A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

    Published on: August 11, 2018

    12.1K

    Related Experiment Videos

    Last Updated: Jul 12, 2025

    Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
    06:03

    Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

    Published on: September 20, 2024

    1.3K
    Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
    08:48

    Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

    Published on: February 16, 2022

    2.9K
    A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
    11:17

    A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

    Published on: August 11, 2018

    12.1K